Clinical Trial Update: Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD) [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update for FM220 in patients with peripheral arterial disease and intermittent claudication; the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• FM220

Snippet

Sponsor: FlowMedic | Conditions: Peripheral Arterial Disease, Intermittent Claudication | Phase 2 | Status: UNKNOWN